NeuroClin Ltd

Today is another important moment in the global fight against dementia with the announcement of Donanemab becoming the second drug to be approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the treatment of early-stage Alzheimer's disease.   Similar to Lecanemab, a drug approved by the MHRA in August, Donanemab has been shown to slow down the progression of Alzheimer’s disease in clinical trials.   We have been heavily involved over the last 25 years in the development and research of treatments for numerous degenerative neurological conditions and view the license granted for Donanemab as another landmark moment in the quest to find a cure for Alzheimer’s disease.   We look forward to our essential ongoing work, continuing to contribute to the growing body of research on disease modifying treatments for dementia and help national health bodies become  more informed when considering the merits of making this drug available to the wider public. https://lnkd.in/d6qNZDfB

Today is another important moment in the global fight against dementia with the announcement of Donanemab becoming the second drug to be approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the treatment of early-stage Alzheimer's disease.   Similar to Lecanemab, a drug approved by the MHRA in August, Donanemab has been shown to slow down the progression of Alzheimer’s disease in clinical trials.   We have been heavily involved over the last 25 years in the development and research of treatments for numerous degenerative neurological conditions and view the license granted for Donanemab as another landmark moment in the quest to find a cure for Alzheimer’s disease.   We look forward to our essential ongoing work, continuing to contribute to the growing body of research on disease modifying treatments for dementia and help national health bodies become  more informed when considering the merits of making this drug available to the wider public. https://lnkd.in/d6qNZDfB

🌟 Introducing The Clinical Corner! 🌟 We’re excited to share the very first issue of our newsletter, where we delve into the inspiring journey of our Clinical Research Manager, Monica Harley. Discover how her dedication to Parkinson’s research is making a difference and how you can get involved in advancing care for those living with Alzheimer’s and Parkinson’s. 📬 Read more about Monica’s passion and commitment to our groundbreaking work! Join us on this journey toward better brain health. Together, we can make a significant impact! #TheClinicalCorner #AlzheimersResearch #ParkinsonsSupport #NeuroClin #ClinicalTrials #HopeForParkinson's

We’re #hiring a new Chief Financial Officer in Motherwell, Scotland. Apply today or share this post with your network. https://lnkd.in/eGzbh-cc

Entrepreneurial Scotland achieves record year supporting Scotland’s next generation of business leaders 🎉 We're proud to announce a record year for our Saltire Scholars Programme, placing 195 students into internships globally, up from 137 in 2023. Through key partnerships with businesses in Scotland, like NeuroClin Ltd, we're helping shape the next generation of entrepreneurial leaders and supporting high-growth companies with top talent. Our 2025 Saltire Scholars Programme is now open for applications! Penultimate and final-year undergraduate students can apply, and companies interested in hosting an intern next summer are invited to register their interest. Read the full story: https://lnkd.in/e_XDfmHj #SaltireScholars #leadershipdevelopment #futureleaders #talent

🎉 Huge congratulations to Entrepreneurial Scotland on a record-breaking year supporting the next generation! 📈 NeuroClin is proud to be part of this incredible journey, contributing to innovative programs and fostering the next wave of careers in healthcare and beyond. Together, we are shaping a brighter future for Scotland’s business landscape. Check out the full story of their inspiring journey and achievements. 🚀👏 https://lnkd.in/e_XDfmHj #EntrepreneurialScotland #BusinessLeadership #ScotlandSuccess

🎉 We’re Back on STV! 📺 We’re excited to announce that our NeuroClin adverts are back on STV tonight! Tune in to catch us during The Chase at 17:58 and My Mum, Your Dad at 21:45. If you spot our ad, let us know in the comments below! 👇 We’d love to hear from you. Thank you for your continued support as we raise awareness for neurological care across Scotland. 💙 #NeuroClinOnSTV #RaisingAwareness #NeurologicalCare #STV #parkinsonsdisease

This new campaign for the Scottish Government around dementia, urges friends and families to rethink their attitudes and maintain social contact and enjoy time with their loved ones. It comes after research found that many people thought of dementia in terms of the latter stages of the disease, not realising that it was progressive and that in the early stages, people can enjoy active and independent lives. “When a person is diagnosed with dementia, their family and friends often struggle to know what to do,” explained Becky Inglis, Senior Marketing Manager at the Scottish Government. “It’s difficult for everyone. With this campaign, we wanted to remind people that it’s the everyday social interactions that help those diagnosed with Dementia; that’s what makes the difference. We wanted to encourage them to do the same things they’ve always done with friends and family. Ultimately for people across Scotland to rethink dementia.” https://lnkd.in/dhwZEF_Z #dementiaawareness #rethinkdementia #alzheimersawarenessmonth #neuroclin #researchmatters

You may have missed on Friday, our Medical Director Jennifer Lynch was interviewed on BBC Radio Scotland Lunchtime spot to discuss her thoughts. Listen to the full interview here and learn more on the NeuroClin Ltd website https://lnkd.in/e4bDRprq #AlzheimersAwareness #dementia #NeuroClinGlasgow #Scotland #bbcscotland #bbcscotlandnews

Fantastic having Anne along delivering dementia friendly training to our staff. We had some amazing feedback from our staff, including that it formed a new perspective on those with Dementia and how we can take steps towards a more accessible future. ✨ All of our staff emphasised the incredible delivery of Anne, it’s not only the fantastic content but Anne’s way to engage and encourage that made the experience so successful. Thanks again from all at NeuroClin